Some in his inner circle have advised him to consider dropping out.
They clashed over the malaria drug hydroxychloroquine and its use as a possible treatment for COVID-19.
The SEC has no plans to delay its Regulation Best Interest rule despite the impact the ongoing coronavirus pandemic has had on U.S. markets.
“This is going to be the hardest and the saddest week of most Americans’ lives, quite frankly,” Jerome Adams said.